Amy Tiersten
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer (NCT03430518) | Amy Tiersten | 2018-05-17 |
Track Amy Tiersten automatically
Every clearance here is in the API, with alerts when new ones post.